Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

All articles

Showing 61–72 of 411 articles

  • Understand the science

    What frozen receptor images show about cagrilintide

    Cagrilintide is a long-acting peptide based on amylin, a hormone associated with signals after eating. For the specific question of how the peptide sits in its receptors, the older direct evidence comes from a 2025 study that visualized cagrilintide bound to several versions of the receptor family.

    Cagrilintide1 source (2025)

  • Check methods and identity

    Which molecule does the name CJC-1295 No DAC describe?

    CJC-1295 No DAC is commonly used as a label for modified growth hormone–releasing factor (1–29), or Mod GRF (1–29). The first question about a paper or catalog entry is whether that name refers to the same molecule in both places.

    CJC-1295 No DAC1 source (2024)

  • Interpret the evidence

    What the growth hormone–releasing hormone receptor can tell us

    CJC-1295 No DAC commonly refers to Mod GRF (1–29), a synthetic 29-residue relative of growth hormone–releasing hormone (GHRH) with four substitutions. Its design raises a specific question about how the original hormone engages its receptor.

    CJC-1295 No DAC2 sources (2020, 2024)

  • Understand the science

    How a change near one end can affect peptide breakdown

    CJC-1295 No DAC generally denotes Mod GRF (1–29), a growth hormone–releasing hormone (GHRH) fragment with four substitutions and no albumin-binding attachment. One of those substitutions helps frame a question about how researchers study peptide stability.

    CJC-1295 No DAC2 sources (1989, 2024)

  • Check methods and identity

    What a growth hormone pulse measures

    CJC-1295 No DAC is a catalog name commonly used for a four-substitution relative of the first 29 residues of growth hormone–releasing hormone (GHRH). What would a study have to measure to show how this compound affects the timing of growth hormone release?

    CJC-1295 No DAC2 sources (1999, 2024)

  • Understand the science

    How a laboratory identified a no-DAC sequence in an unknown sample

    CJC-1295 No DAC commonly names Mod GRF (1–29), an engineered version of the first 29 amino acids of growth hormone–releasing hormone (GHRH). How can a laboratory establish that an unknown preparation contains a peptide consistent with that description?

    CJC-1295 No DAC2 sources (2010, 2024)

  • Understand the science

    From a growth hormone signal to an outcome in people

    CJC-1295 No DAC generally refers to Mod GRF (1–29), a 29-residue analogue designed around the natural signal for growth hormone release. An important research question is how a hormone measurement could be connected to an outcome that matters to people with growth hormone deficiency.

    CJC-1295 No DAC1 source (2024)

  • Check methods and identity

    What a 2026 horse-plasma test detected

    CJC-1295 With DAC is a synthetic analogue of growth hormone–releasing hormone (GHRH) with a drug affinity complex that can form covalent bonds with blood proteins. That attachment raises an analytical question about what a laboratory needs to detect.

    CJC-1295 With DAC2 sources (2024, 2026)

  • Understand the science

    How long did growth hormone and IGF-1 change in early human trials?

    CJC-1295 With DAC is an investigational form of a growth hormone–releasing hormone (GHRH) analogue. Its attached drug affinity complex (DAC) allows it to bind to blood proteins. Early studies asked how long the circulating peptide and its effects could be measured in healthy adults.

    CJC-1295 With DAC2 sources (2005, 2024)

  • Interpret the evidence

    The difference between growth hormone peaks and troughs

    CJC-1295 With DAC is a growth hormone–releasing hormone (GHRH) analogue that attaches to proteins in the blood, extending exposure. A human experiment asked whether sustained stimulation would change the timing or the size of growth hormone pulses.

    CJC-1295 With DAC2 sources (2006, 2024)

  • Understand the science

    What the original albumin-binding experiments established

    CJC-1295 With DAC is an engineered form of growth hormone–releasing factor (GRF), also called growth hormone–releasing hormone. Its drug affinity complex (DAC) was designed to react with the blood protein albumin. The original 2005 development study provides older direct evidence for that design.

    CJC-1295 With DAC2 sources (2005, 2026)

  • Explore study findings

    What an exploratory blood-protein study can establish

    CJC-1295 With DAC is an engineered growth hormone–releasing hormone (GHRH) analogue that links to blood proteins. Researchers have used it in human experiments to perturb the growth hormone pathway and look for measurable changes farther downstream.

    CJC-1295 With DAC2 sources (2009, 2024)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)